Teijin Of Japan Makes Third U.S. Buy Of Home Medical Device Maker
This article was originally published in PharmAsia News
Japan's Teijin said it has bought Home Therapy Equipment, its third acquisition of a U.S. maker of medical devices for the home. Teijin made the buy through its Associated Healthcare Systems subsidiary, which the Japanese firm acquired earlier this year. The purchases are part of Teijin's effort to move beyond Japan where its Teijin Pharma controls about 60 percent of the market for home respiratory equipment, to the much larger U.S. market. (Click here for more - a subscription may be required
You may also be interested in...
A flurry of financial appointments has been seen across the off-patent industry, involving major players Dr Reddy’s, Biocon, Mayne Pharma and Xbrane Biopharma.
Aurobindo has agreed to sell its US-based Natrol dietary supplements business at a significant premium to the $132.5m it paid in late 2014, as the Indian firm continues to drive into complex formulations in the US, including injectables and biosimilars.
GlaxoSmithKline’s third quarter results included a 9% decline in sales in its vaccine business, but this was offset by tight cost controls and restructuring benefits; the company expects to continue investing in its pipeline and new product launches.